Mixed response from industry to additional German certification service
This article was originally published in Clinica
The German notified body, TUV Suddeutschland, is offering a new certification service, which it says could give medical devices a competitive edge over those products that only carry the obligatory CE mark.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.